DE:NV40 / Cellectar Biosciences, Inc. - Net Long/Short Value

Cellectar Biosciences, Inc.
DE ˙ DB ˙ US15117F8077
DE:NV40 / Cellectar Biosciences, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Vanguard Global Advisers, LLC
SBI Securities Co., Ltd.
Us Bancorp \de\
Geode Capital Management, Llc
Advisor Group Holdings, Inc.
UBS Group AG
Jones Financial Companies Lllp
Fmr Llc
Danske Bank A/s
TD Waterhouse Canada Inc.
Warberg Asset Management LLC
Vanguard Group Inc
Vanguard Fiduciary Trust Co
Sequoia Financial Advisors, LLC
Morgan Stanley
Riverview Capital Advisers, LLC
Vanguard Capital Management Llc
Bleichroeder LP
BlackRock, Inc.
Tower Research Capital LLC (TRC)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:CLRB 2,75 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista